ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 460 out of 3593

$689K Total Retail Price of All Prescriptions

Rank: 315 out of 3593

368 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,620 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 615 575 1 1
LISINOPRIL 329 263 2 2
AMLODIPINE BESYLATE 319 284 3 3
METFORMIN HCL 258 211 4 6
METOPROLOL TARTRATE 233 203 5 8
OMEPRAZOLE 211 156 6 5
LEVOTHYROXINE SODIUM 208 200 7 4
ALENDRONATE SODIUM 179 150 8 22
ZOLPIDEM TARTRATE 158 140 9 12
HYDROCODONE-ACETAMINOPHEN 150 105 S3 10 7
ATORVASTATIN CALCIUM 146 133 11 15
ENALAPRIL MALEATE 144 138 12 38
HYDROCHLOROTHIAZIDE 140 106 13 10
CARVEDILOL 139 133 14 23
SYNTHROID 136 123 15 51
IBUPROFEN 133 104 16 43
LOSARTAN POTASSIUM 117 114 17 14
AZITHROMYCIN 117 98 17 34
TRAMADOL HCL 114 96 19 17
CLOPIDOGREL 114 111 19 30
CIPROFLOXACIN HCL 113 88 21 52
FENOFIBRATE 112 67 22 39
ATENOLOL 109 95 23 11
FUROSEMIDE 108 98 24 9
PLAVIX 100 86 25 42
AMLODIPINE BESYLATE-BENAZEPRIL 100 76 25 65
TAMSULOSIN HCL 95 80 27 33
ALPRAZOLAM 94 78 28 37
NEXIUM 93 80 29 36
CITALOPRAM HBR 91 80 30 25
BENAZEPRIL HCL 90 81 31 69
OXYCODONE HCL 87 27 S2 32 59
SERTRALINE HCL 86 73 33 28
LOVAZA 83 58 34 106
TEMAZEPAM 82 78 35 56
TRICOR 78 55 36 130
DONEPEZIL HCL 76 76 37 31
CRESTOR 76 56 37 21
POTASSIUM CHLORIDE 75 58 39 24
ADVAIR DISKUS 71 53 40 47
GABAPENTIN 70 44 41 16
LOVASTATIN 69 69 42 20
DICLOFENAC SODIUM 68 50 43 74
LORAZEPAM 66 55 44 98
PROAIR HFA 66 38 44 54
NIASPAN 66 46 44 186
CLOTRIMAZOLE-BETAMETHASONE 64 58 47 94
VERAPAMIL ER 62 62 48 99
JANUVIA 61 55 49 81
FLUTICASONE PROPIONATE 60 51 50 32
METOPROLOL SUCCINATE 59 56 51 19
GLIPIZIDE 58 50 52 40
VOLTAREN 57 52 53 85
SINGULAIR 56 47 54 77
FINASTERIDE 56 56 54 79
DIOVAN 53 51 56 46
GLIPIZIDE ER 52 44 57 101
CYMBALTA 51 48 58 73
OXYCODONE HCL-ACETAMINOPHEN 51 45 S2 58 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.